Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Current Opinion in Molecular Therapeutics|March 12, 2004
Therapeutic cancer vaccinesBruce Acres, Stephane Paul, Helene Haegel-Kronenberger, et al.
Plos One|March 19, 2015
Involvement of neutrophil hyporesponse and the role of Toll-like receptors in human immunodeficiency virus 1 protectionJuan C Hernandez, Diana M Giraldo, Stephane Paul, et al.
BMC Immunology|December 26, 2021
Adalimumab and anti-adalimumab LISA-TRACKER immunoassays performance criteria for therapeutic drug monitoring of adalimumab-amgen biosimilar (ABP501)Fabien Francois, Loubna Naimi, Xavier Roblin, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 10, 2014
Prevention and treatment of postoperative Crohn's disease recurrence with anti-TNF therapy: a meta-analysis of controlled trialsAmelie Carla-Moreau, Stephane Paul, Xavier Roblin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 5, 2024
Risankizumab Concentration but not IL-22 Levels Are Associated With Clinical and Biochemical Remission in Patients With Crohn's DiseaseXavier Roblin, Estelle Moschetti, Mathilde Barrau, et al.
Journal of Clinical Medicine|August 29, 2020
Point-of-Care Assays Could Be Useful for Therapeutic Drug Monitoring of IBD Patients in a Proactive Strategy with AdalimumabMohamad Cherry, Dominique Dutzer, Yara Nasser, et al.
Therapeutic Drug Monitoring|November 16, 2018
Evaluation of Infliximab and Anti-infliximab LISA-TRACKER Immunoassays for the Therapeutic Drug Monitoring of SB2 Infliximab BiosimilarAlexandre Jentzer, Anne-Emmanuelle Berger, Rémi Labetoulle, et al.
Digestive Diseases and Sciences|June 28, 2018
Comparison of Point-of-Care and Classical Immunoassays for the Monitoring Infliximab and Antibodies Against Infliximab in IBDYara Nasser, Rémi Labetoulle, Ines Harzallah, et al.
Carbohydrate Polymers|June 14, 2017
Ternary polysaccharide complexes: Colloidal drug delivery systems stabilized in physiological mediaDanjun Wu, Agathe Ensinas, Bernard Verrier, et al.
NPJ Vaccines|June 28, 2022
Towards the future exploration of mucosal mRNA vaccines against emerging viral diseases; lessons from existing next-generation mucosal vaccine strategiesSodiq A Hameed, Stephane Paul, Giann Kerwin Y Dellosa, et al.
Pageof 7